| Title |
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, September 2010
|
| DOI | 10.2147/ndt.s6430 |
| Pubmed ID | |
| Authors |
Samuel Frank |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| United States | 1 | <1% |
| Italy | 1 | <1% |
| France | 1 | <1% |
| Unknown | 109 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 18% |
| Student > Master | 16 | 14% |
| Student > Bachelor | 11 | 10% |
| Student > Ph. D. Student | 8 | 7% |
| Other | 7 | 6% |
| Other | 22 | 19% |
| Unknown | 29 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 24% |
| Agricultural and Biological Sciences | 14 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 9% |
| Neuroscience | 9 | 8% |
| Biochemistry, Genetics and Molecular Biology | 6 | 5% |
| Other | 14 | 12% |
| Unknown | 33 | 29% |